Passage Bio Announces 2024 Annual Meeting of Stockholders
Ticker: PASG · Form: DEF 14A · Filed: Apr 9, 2024 · CIK: 1787297
Sentiment: neutral
Topics: proxy statement, annual meeting, stockholders, director election, independent auditor
TL;DR
<b>Passage Bio will hold its 2024 virtual Annual Meeting of Stockholders on May 21, 2024, to elect directors and ratify auditors.</b>
AI Summary
Passage BIO, Inc. (PASG) filed a Proxy Statement (DEF 14A) with the SEC on April 9, 2024. Passage Bio, Inc. will hold its 2024 Annual Meeting of Stockholders on May 21, 2024, at 9:00 a.m. Eastern Time via a virtual meeting. The meeting will allow stockholders to elect two Class I directors for a three-year term. Stockholders will also vote to ratify the appointment of KPMG LLP as the independent registered public accounting firm for fiscal year 2024. The record date for stockholders entitled to notice and voting is March 28, 2024. Proxy materials will be mailed on or about April 9, 2024.
Why It Matters
For investors and stakeholders tracking Passage BIO, Inc., this filing contains several important signals. The election of directors is a standard governance procedure to ensure board continuity and oversight. Ratifying the independent auditor is crucial for maintaining financial transparency and investor confidence.
Risk Assessment
Risk Level: — Passage BIO, Inc. shows moderate risk based on this filing. The filing is a routine proxy statement for an annual meeting and does not contain new financial or operational information that would indicate significant risk.
Analyst Insight
Stockholders should review the proxy materials to make informed voting decisions on director elections and auditor ratification.
Key Numbers
- 2 — Class I directors (To be elected at the meeting)
- 3-year term — Director term (For elected Class I directors)
- 2024 — Fiscal year (For which KPMG LLP is appointed as auditor)
Key Players & Entities
- Passage Bio, Inc. (company) — Registrant
- KPMG LLP (company) — independent registered public accounting firm
- May 21, 2024 (date) — 2024 Annual Meeting of Stockholders date
- March 28, 2024 (date) — Record date for stockholders
- April 9, 2024 (date) — Expected mailing date for Notice of Internet Availability
FAQ
When did Passage BIO, Inc. file this DEF 14A?
Passage BIO, Inc. filed this Proxy Statement (DEF 14A) with the SEC on April 9, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Passage BIO, Inc. (PASG).
Where can I read the original DEF 14A filing from Passage BIO, Inc.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Passage BIO, Inc..
What are the key takeaways from Passage BIO, Inc.'s DEF 14A?
Passage BIO, Inc. filed this DEF 14A on April 9, 2024. Key takeaways: Passage Bio, Inc. will hold its 2024 Annual Meeting of Stockholders on May 21, 2024, at 9:00 a.m. Eastern Time via a virtual meeting.. The meeting will allow stockholders to elect two Class I directors for a three-year term.. Stockholders will also vote to ratify the appointment of KPMG LLP as the independent registered public accounting firm for fiscal year 2024..
Is Passage BIO, Inc. a risky investment based on this filing?
Based on this DEF 14A, Passage BIO, Inc. presents a moderate-risk profile. The filing is a routine proxy statement for an annual meeting and does not contain new financial or operational information that would indicate significant risk.
What should investors do after reading Passage BIO, Inc.'s DEF 14A?
Stockholders should review the proxy materials to make informed voting decisions on director elections and auditor ratification. The overall sentiment from this filing is neutral.
Risk Factors
- Compliance with SEC Regulations [low — regulatory]: The company must comply with all SEC rules and regulations regarding proxy solicitations and annual meetings.
- Virtual Meeting Logistics [low — operational]: Ensuring a smooth and accessible virtual meeting experience for all stockholders is critical for participation and voting.
Key Dates
- 2024-05-21: 2024 Annual Meeting of Stockholders — Key date for voting on directors and auditor ratification.
- 2024-03-28: Record Date — Determines which stockholders are entitled to vote.
- 2024-04-09: Mailing of Notice of Internet Availability — Initiates the proxy material distribution process.
Glossary
- DEF 14A
- Definitive Proxy Statement filed with the SEC. (This filing type indicates the company is providing final proxy materials to shareholders for a meeting.)
- Class I directors
- A class of directors on a company's board, typically elected for staggered terms. (Stockholders will vote on the election of these directors, impacting board composition and strategy.)
- Independent registered public accounting firm
- An external audit firm hired to provide an independent opinion on the company's financial statements. (Ratification of this firm is a key governance item for ensuring financial integrity.)
Filing Stats: 4,655 words · 19 min read · ~16 pages · Grade level 14.4 · Accepted 2024-04-09 06:02:16
Filing Documents
- tm249796d1_def14a.htm (DEF 14A) — 466KB
- tm249796d1_pre14aimg001.jpg (GRAPHIC) — 4KB
- tm249796d1_pre14aimg002.jpg (GRAPHIC) — 187KB
- tm249796d1_pre14aimg003.jpg (GRAPHIC) — 227KB
- 0001104659-24-044915.txt ( ) — 1042KB
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 19 DELINQUENT SECTION 16(A) REPORTS 21 EXECUTIVE OFFICERS 22
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 23 EQUITY COMPENSATION PLAN INFORMATION 32 CERTAIN RELATIONSHIPS AND RELATED-PARTY TRANSACTIONS 33 ADDITIONAL INFORMATION 34 OTHER MATTERS 35 PASSAGE BIO, INC. One Commerce Square 2005 Market Street, 39th Floor Philadelphia, PA 19103 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS April 9, 2024 INFORMATION ABOUT SOLICITATION AND VOTING The accompanying proxy is solicited on behalf of the Board of Directors of Passage Bio, Inc. (Passage Bio or the Company) for use at Passage Bio’s 2024 Annual Meeting of Stockholders (Annual Meeting) to be held via a virtual meeting. You will be able to participate in the Annual Meeting and vote during the Annual Meeting via live webcast by visiting www.virtualshareholdermeeting.com/PASG2024 on Tuesday, May 21, 2024 at 9:00 a.m., Eastern Time, and any adjournment or postponement thereof. You will need the control number included on your proxy card or voting instruction form, or included in the e-mail to you if you received the proxy materials by e-mail, as such number will be required in order for stockholders to gain access to the virtual Annual Meeting. We are making this proxy statement, the accompanying form of proxy and our Annual Report on Form 10-K for the year ended December 31, 2023 first available to stockholders on or about April 9, 2024. An electronic copy of this proxy statement and Annual Report on Form 10-K are available at https://investors.passagebio.com/financials-and-filings/sec-filings. Internet Availability of Proxy Materials Under rules adopted by the U.S. Securities and Exchange Commission (the SEC), we are furnishing proxy materials to our stockholders primarily via the internet, instead of mailing printed copies to each stockholder. On or about April 9, 2024, we expect to send to our stockholders a Notice of Internet Availability containing instructions on how to access our proxy materials, including our proxy statement and our Annual Repor